Tristel shares gain after return to double-digit growth and improved royalties
- Shares gain as company returns to growth- US FDA clearance decision expected mid-2023- Parker Labs royalties renegotiated upwardsShares in infection prevention specialist Tristel (TSTL:AIM) jumped 6% to 330p on Monday as investors...
20 February 2023